Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study

Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study

Background: In February 2021, Colombia began mass vaccination against COVID-19 using mainly BNT162b2 and CoronaVac vaccines. We aimed to estimate vaccine effectiveness (VE) to prevent COVID-19 symptomatic cases, hospitalization, critical care admission, and deaths in a cohort of 796,072 insured subj...

Full description

Bibliographic Details
Main Authors: Alvis-Guzmán, N. (Author), Alvis-Zakzuk, N.J (Author), Dueñas-Castell, C. (Author), Fernández, J.C (Author), Hernández, J. (Author), Hoz-Restrepo, F.D.L (Author), Jit, M. (Author), Paternina-Caicedo, A. (Author), Paz-Wilches, J.J (Author), Rojas-Suarez, J. (Author), Smith, A.D (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2022
Subjects:
Covid-19
Mortality
Vaccine effectiveness
Vaccines
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items